Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing — Worldwide, March–October 2021
by from Morbidity and Mortality Weekly Report (MMWR) on (#60EGX)
This report describes global novel type 2 oral poliovirus vaccine genomic surveillance during an outbreak response.